Have a look at RAC, there's heaps of info on the HC forum. It's biotech, not tech. IMO it's a lot more derisked than normal biotechs because of the historic trials.
Don't exactly want to be cross promoting, so ill say I'm excited to see what nc6 management can do this year. They have potential company makers with their collaboration with grasim as well as with celluair.
There should be news on culluair soon I think?
NC6 Price at posting:
13.5¢ Sentiment: Buy Disclosure: Held
